ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
enGene Holdings Inc

enGene Holdings Inc (ENGN)

4.96
-0.25
(-4.80%)
Closed March 23 4:00PM
5.17
0.21
(4.23%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
4.96
Bid
4.75
Ask
5.59
Volume
79,466
4.67 Day's Range 5.33
4.42 52 Week Range 18.40
Market Cap
Previous Close
5.21
Open
5.18
Last Trade
2
@
5.1099
Last Trade Time
Financial Volume
$ 386,397
VWAP
4.8624
Average Volume (3m)
106,624
Shares Outstanding
50,977,560
Dividend Yield
-
PE Ratio
-2.64
Earnings Per Share (EPS)
-1.96
Revenue
-
Net Profit
-99.92M

About enGene Holdings Inc

enGene Holdings Inc. is a holding company. The Company, through its subsidiary, enGene Inc., is engaged in developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues. The Company's proprietary dually derived chitosan (DDX) platform has a high degree o... enGene Holdings Inc. is a holding company. The Company, through its subsidiary, enGene Inc., is engaged in developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues. The Company's proprietary dually derived chitosan (DDX) platform has a high degree of payload flexibility, including DNA and various forms of RNA with broad tissue and disease application. In preclinical animal and in vitro models, the Company's DDX technology has been demonstrated to effectively induce expression of therapeutic genes following delivery to the lung, gastrointestinal tract, and urinary tract, and its lead product detalimogene voraplasmid (EG-70) is being developed for the treatment of bacillus calmette-guerin (BCG)-resistant non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS). EG-70 is a novel non-viral gene therapy designed to elicit a local immune response following the delivery to the bladder urothelium. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Vancouver, British Columbia, Can
Founded
-
enGene Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ENGN. The last closing price for enGene was $5.21. Over the last year, enGene shares have traded in a share price range of $ 4.42 to $ 18.40.

enGene currently has 50,977,560 shares outstanding. The market capitalization of enGene is $265.59 million. enGene has a price to earnings ratio (PE ratio) of -2.64.

ENGN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4-7.462686567165.365.64.9194295.26781103CS
4-1.26-20.25723472676.226.694.78313515.6346773CS
12-1.22-19.74110032366.188.444.781066246.74559738CS
26-2.22-30.91922005577.18114.421590237.06543167CS
52-12.58-71.721778791317.5418.44.421313778.14449887CS
156-12.03-70.806356680416.99434.421102048.80259041CS
260-12.03-70.806356680416.99434.421102048.80259041CS

ENGN - Frequently Asked Questions (FAQ)

What is the current enGene share price?
The current share price of enGene is $ 4.96
How many enGene shares are in issue?
enGene has 50,977,560 shares in issue
What is the market cap of enGene?
The market capitalisation of enGene is USD 265.59M
What is the 1 year trading range for enGene share price?
enGene has traded in the range of $ 4.42 to $ 18.40 during the past year
What is the PE ratio of enGene?
The price to earnings ratio of enGene is -2.64
What is the reporting currency for enGene?
enGene reports financial results in CAD
What is the latest annual profit for enGene?
The latest annual profit of enGene is CAD -99.92M
What is the registered address of enGene?
The registered address for enGene is SUITE 2600, THREE BENTALL CENTRE, 595 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V7X 1L3
What is the enGene website address?
The website address for enGene is www.engene.com
Which industry sector does enGene operate in?
enGene operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SGLYSingularity Future Technology Ltd
$ 1.6799
(143.43%)
30.76M
WINVWinVest Acquisition Corporation
$ 25.00
(107.30%)
463
VVPRVivoPower International PLC
$ 1.2899
(52.13%)
65.08M
RNAZTransCode Therapeutics Inc
$ 1.12
(45.45%)
216.22M
GLTOGalecto Inc
$ 6.00
(44.93%)
10.71M
YHCLQR House Inc
$ 0.40
(-82.38%)
38.32M
KZIAKazia Therapeutics Ltd
$ 0.9759
(-80.02%)
55.66k
DMNDamon Inc
$ 0.0373
(-70.02%)
304.17M
TCBPTC BioPharm Holdings PLC
$ 0.5046
(-67.23%)
5.9M
SOWGSow Good Inc
$ 1.53
(-44.36%)
698.02k
DMNDamon Inc
$ 0.0373
(-70.02%)
304.17M
NVDANVIDIA Corporation
$ 117.70
(-0.70%)
264.42M
RNAZTransCode Therapeutics Inc
$ 1.12
(45.45%)
216.22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.03
(10.66%)
175.77M
HOLOMicroCloud Hologram Inc
$ 1.00
(32.36%)
141.98M